Capital International Investors’s Tandem Diabetes Care TNDM Stock Holding History

Capital International Investors’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-718,038	Closed	-$25.9M	–	466
2024 Q4	$25.9M	Buy	718,038 +79,810	+13%	+$2.7M	﹤0.01%	383
2024 Q3	$27.1M	Buy	638,228 +31,759	+5%	+$1.35M	0.01%	371
2024 Q2	$24.4M	Sell	606,469 -410,726	-40%	-$17.1M	0.01%	369
2024 Q1	$36M	Sell	1,017,195 -66,366	-6%	-$1.78M	0.01%	347
2023 Q4	$32.1M	Sell	1,083,561 -710,626	-40%	-$14.7M	0.01%	353
2023 Q3	$37.3M	Buy	1,794,187 +558,943	+45%	+$15.4M	0.01%	336
2023 Q2	$30.3M	Sell	1,235,244 -24,723	-2%	-$795K	0.01%	363
2023 Q1	$51.2M	Buy	1,259,967 +24,723	+2%	+$1.02M	0.01%	334
2022 Q4	$55.5M	Buy	+1,235,244	New	+$55.9M	0.01%	321

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors's TNDM Position: Q1 2025 in Review

Capital International Investors sold out of Tandem Diabetes Care (TNDM) in Q1 2025, closing a stake of 718,038 shares — an estimated $25.9M sold.

Capital International Investors first reported a position in TNDM in Q4 2022 and held it in 9 quarters. The position peaked at $55.5M in Q4 2022. 275 funds tracked by Wall St. Rank hold TNDM as of Q1 2025.

Capital International Investors reported no remaining Tandem Diabetes Care position as of Q1 2025 after selling out during the quarter.
Capital International Investors sold 718,038 Tandem Diabetes Care shares in Q1 2025, an estimated $25.9M.
Capital International Investors first reported a position in Tandem Diabetes Care in Q4 2022 and held it in 9 quarters.
Capital International Investors's Tandem Diabetes Care position peaked at $55.5M in Q4 2022.
275 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2025.

Based on Capital International Investors's 13F filing for Q1 2025, filed 12 May 2025.